| Symbol | Company | Weighting |
|---|---|---|
| BSX | BOSTON SCIENTIFIC | 6.44% |
| UNH | UNITEDHEALTH GROUP INC | 5.34% |
| GILD | GILEAD SCIENCES INC | 4.89% |
| LLY | ELI LILLY CORP | 4.63% |
| ABBV | ABBVIE INC | 4.60% |
| VRTX | VERTEX PHARMACEUTICALS INC | 4.57% |
| CI | THE CIGNA GROUP | 4.41% |
| EW | EDWARDS LIFESCIENCES CORP | 4.39% |
| BMY | BRISTOL MYERS SQUIBB CO | 4.19% |
| AMGN | AMGEN CORP | 3.98% |
| MDT | MEDTRONIC PLC | 3.93% |
| JNJ | JOHNSON & JOHNSON | 3.82% |
| CVS | CVS HEALTH CORPORATION | 3.73% |
| HALO | HALOZYME THERAPEUTICS INC | 3.57% |
| BDX | BECTON DICKINSON & CO | 3.45% |
| NTRA | NATERA INC | 3.41% |
| EHC | ENCOMPASS HEALTH CORP NPV | 3.35% |
| TMO | THERMO FISHER SCIENTIFIC INC | 3.28% |
| PFE | PFIZER INC | 3.14% |
| ZTS | ZOETIS INC | 3.12% |
| MRK | MERCK & CO. NEW | 2.74% |
| REGN | REGENERON PHARMACEUTICALS | 2.45% |
| UTHR | UNITED THERAPEUTICS CORPS | 1.97% |
| PEN | PENUMBRA INC | 1.55% |
| VEEV | VEEVA SYSTEMS INC CLASS A | 1.49% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.25% |
| HQY | HEALTHEQUITY INC | 1.18% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.04% |
| ILMN | ILLUMINA INC | 0.82% |
| DXCM | DEXCOM INC | 0.82% |
| BIIB | BIOGEN INC | 0.73% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.71% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.61% |
| EVH | EVOLENT HEALTH INC (CLASS A) | 0.33% |
| GRAL | GRAIL INC | 0.04% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available), click here or contact us.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.
© 2025 Guggenheim Investments. All Rights Reserved.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
FOR MERRILL LYNCH ADVISOR USE ONLY
This material may not be reproduced or shown to the members of the general public or used in written form as sales literature; any such use would be contrary to the FINRA Conduct Rules.
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.
